Trial Site Detail

 

Drug:
Imatinib + Atezolizumab
Trial:
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments (ATEZOGIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Centre Léon Bérard

28 rue Laennec     
Lyon , Rhone 69373
France

 

Principal Investigator:
 Mehdi BRAHMI, MD
Contact:
 +33 4 78 78 59 73 mehdi.brahmi@lyon.unicancer.fr
Activation Status of this Site:
 Active
Notes about this Site:
Centre Léon Bérard Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.